{"id":"iv-placebo-saline","safety":{"commonSideEffects":[{"rate":null,"effect":"Injection site reactions (pain, erythema)"},{"rate":null,"effect":"Fluid overload (with excessive volume)"},{"rate":null,"effect":"Hyponatremia (rare, with very high volumes)"}]},"_chembl":null,"_dailymed":null,"mechanism":{"_ai_source":"claude-haiku-4.5","explanation":"Intravenous saline (0.9% sodium chloride) is an isotonic crystalloid fluid used as a vehicle or placebo control in clinical trials. It serves no therapeutic purpose beyond maintaining fluid balance and is used to blind study participants and investigators to treatment allocation. Any observed clinical effects in the placebo arm are attributable to natural disease progression, regression to the mean, or placebo response rather than pharmacological action.","oneSentence":"IV saline placebo has no active pharmacological mechanism; it is a control comparator consisting of sterile sodium chloride solution.","_ai_confidence":"high"},"_scrapedAt":"2026-03-27T23:50:41.542Z","_scrapedBy":"cloudflare-swarm","_wikipedia":null,"indications":{"approved":[{"name":"Clinical trial control / placebo comparator (not a therapeutic indication)"}]},"trialDetails":[{"nctId":"NCT07149649","phase":"PHASE2, PHASE3","title":"Magnesium Supplementation in Advanced Non-small Cell Lung Cancer (NSCLC)","status":"NOT_YET_RECRUITING","sponsor":"Swiss Cancer Institute","startDate":"2026-07","conditions":"Metastatic NSCLC - Non-Small Cell Lung Cancer","enrollment":230},{"nctId":"NCT05652504","phase":"PHASE1","title":"Safety Evaluation of PfSPZ Vaccine in Pregnant Women in Mali (MalVIP1)","status":"SUSPENDED","sponsor":"National Institute of Allergy and Infectious Diseases (NIAID)","startDate":"2026-04-01","conditions":"Malaria","enrollment":400},{"nctId":"NCT06128629","phase":"PHASE3","title":"MAGNITUDE: A Phase 3 Study of NTLA-2001 in Participants With Transthyretin Amyloidosis With Cardiomyopathy (ATTR-CM)","status":"RECRUITING","sponsor":"Intellia Therapeutics","startDate":"2023-12-13","conditions":"Transthyretin Amyloidosis (ATTR) With Cardiomyopathy","enrollment":1200},{"nctId":"NCT07459166","phase":"PHASE2","title":"A Phase 2 Safety, Tolerability, PK, and Efficacy Study of CS-1103 Following Fentanyl Challenge With Naloxone Blockade","status":"NOT_YET_RECRUITING","sponsor":"Clear Scientific, Inc.","startDate":"2026-04","conditions":"Fentanyl Overdose, Fentanyl Poisoning","enrollment":16},{"nctId":"NCT07262060","phase":"PHASE2","title":"Improving Preterm Kidney Outcomes With Caffeine","status":"NOT_YET_RECRUITING","sponsor":"University of Wisconsin, Madison","startDate":"2026-04","conditions":"Kidney Injury, Pre-Term","enrollment":102},{"nctId":"NCT05139316","phase":"PHASE3","title":"A Study of Adeno-Associated Virus Serotype 8-Mediated Gene Transfer of Glucose-6-Phosphatase in Patients With Glycogen Storage Disease Type Ia (GSDIa)","status":"COMPLETED","sponsor":"Ultragenyx Pharmaceutical Inc","startDate":"2021-11-08","conditions":"Glycogen Storage Disease Type IA","enrollment":49},{"nctId":"NCT07493577","phase":"PHASE1, PHASE2","title":"Induced Suppression of Platelet Activity in Aneurysmal Subarachnoid Hemorrhage Management-2 (iSPASM-2)","status":"NOT_YET_RECRUITING","sponsor":"Dr David Hasan, M.D.","startDate":"2026-07-23","conditions":"Aneurysmal Subarachnoid Hemorrhage","enrollment":82},{"nctId":"NCT03336398","phase":"PHASE2","title":"Investigation of the NMDA Antagonist Ketamine as a Treatment for Tinnitus","status":"COMPLETED","sponsor":"New York State Psychiatric Institute","startDate":"2019-09-01","conditions":"Tinnitus","enrollment":42},{"nctId":"NCT07490457","phase":"NA","title":"Intraoperative Ketamine for Chronic Postoperative Pain After Open-Heart Surgery","status":"NOT_YET_RECRUITING","sponsor":"Bursa City Hospital","startDate":"2026-04-15","conditions":"Cardiac Anaesthesia, Chronic Pain, Post Operative Pain, Chronic","enrollment":100},{"nctId":"NCT05120830","phase":"PHASE1, PHASE2","title":"NTLA-2002 in Adults With Hereditary Angioedema (HAE)","status":"ACTIVE_NOT_RECRUITING","sponsor":"Intellia Therapeutics","startDate":"2021-12-10","conditions":"Hereditary Angioedema","enrollment":37},{"nctId":"NCT07224711","phase":"PHASE4","title":"The Impact of Perioperative Lidocaine Infusions on Enhanced Recovery After Non-Cardiac Surgery","status":"NOT_YET_RECRUITING","sponsor":"Vanderbilt University Medical Center","startDate":"2026-07-01","conditions":"Pain, Post Operative Analgesia, Opioid Consumption, Postoperative","enrollment":2290},{"nctId":"NCT06229483","phase":"PHASE3","title":"The Effects of Intraoperative Tranexamic Acid on Perioperative Bleeding In Craniotomies","status":"RECRUITING","sponsor":"Stephen Lownie","startDate":"2024-04-03","conditions":"Brain Tumor, Bleeding","enrollment":102},{"nctId":"NCT07048314","phase":"PHASE1, PHASE2","title":"Stem Cells for Erectile Dysfunction Post RALP","status":"NOT_YET_RECRUITING","sponsor":"The Methodist Hospital Research Institute","startDate":"2026-03-10","conditions":"Erectile Dysfunction, Prostate Cancer","enrollment":40},{"nctId":"NCT03418038","phase":"PHASE2","title":"Ascorbic Acid and Chemotherapy for the Treatment of Relapsed or Refractory Lymphoma, CCUS, and Chronic Myelomonocytic Leukemia","status":"RECRUITING","sponsor":"Mayo Clinic","startDate":"2018-03-23","conditions":"Clonal Cytopenia of Undetermined Significance, High Grade B-Cell Lymphoma With MYC and BCL2 or BCL6 Rearrangements, Recurrent Diffuse Large B-Cell Lymphoma","enrollment":80},{"nctId":"NCT06226805","phase":"PHASE2","title":"Study of BB-031 in Acute Ischemic Stroke Patients (RAISE)","status":"RECRUITING","sponsor":"Basking Biosciences, Inc.","startDate":"2024-07-31","conditions":"Acute Ischemic Stroke","enrollment":228},{"nctId":"NCT07184801","phase":"PHASE3","title":"Safety and Efficacy of Dexmedetomidate vs. Midazolam for Procedural Sedation During Medical Thoracoscopy","status":"RECRUITING","sponsor":"Post Graduate Institute of Medical Education and Research, Chandigarh","startDate":"2025-10-01","conditions":"Medical Thoracoscopy","enrollment":56},{"nctId":"NCT04512235","phase":"PHASE3","title":"A Study to Evaluate the Efficacy and Safety of CAEL-101 in Patients With Mayo Stage IIIa AL Amyloidosis (CARES)","status":"ACTIVE_NOT_RECRUITING","sponsor":"Alexion Pharmaceuticals, Inc.","startDate":"2020-11-03","conditions":"AL Amyloidosis","enrollment":281},{"nctId":"NCT04504825","phase":"PHASE3","title":"A Study to Evaluate the Efficacy and Safety of CAEL-101 in Patients With Mayo Stage IIIb AL Amyloidosis (CARES)","status":"ACTIVE_NOT_RECRUITING","sponsor":"Alexion Pharmaceuticals, Inc.","startDate":"2020-08-25","conditions":"AL Amyloidosis","enrollment":125},{"nctId":"NCT07474909","phase":"NA","title":"Perineural vs Intravenous Dexamethasone as an Adjuvant to Brachial Plexus Block in Pediatric Hand Surgery","status":"NOT_YET_RECRUITING","sponsor":"Poznan University of Medical Sciences","startDate":"2026-04-01","conditions":"Hand Injuries and Disorders, Wrist Sprain","enrollment":150},{"nctId":"NCT05065424","phase":"PHASE4","title":"Premedication for Less Invasive Surfactant Administration Study (PRELISA)","status":"COMPLETED","sponsor":"University of Texas Southwestern Medical Center","startDate":"2022-04-06","conditions":"Respiratory Distress Syndrome, Newborn","enrollment":58},{"nctId":"NCT02726711","phase":"PHASE1","title":"Reduction in Splanchnic Capacitance Contributes to Sympathetically Dependent Hypertension in Autonomic","status":"ACTIVE_NOT_RECRUITING","sponsor":"Vanderbilt University","startDate":"2016-04","conditions":"Multiple System Atrophy, Orthostatic Hypotension, Supine Hypertension","enrollment":2},{"nctId":"NCT06556563","phase":"PHASE3","title":"EF-41/KEYNOTE D58: Phase 3 Study of Optune Concomitant With Temozolomide Plus Pembrolizumab in Newly Diagnosed Glioblastoma","status":"RECRUITING","sponsor":"NovoCure GmbH","startDate":"2025-02-03","conditions":"Glioblastoma","enrollment":741},{"nctId":"NCT04838301","phase":"PHASE2","title":"Allopregnanolone Regenerative Therapeutic for Mild Alzheimer's Disease","status":"RECRUITING","sponsor":"University of Arizona","startDate":"2023-08-15","conditions":"Alzheimer Dementia, Late Onset Alzheimer Disease, Neurodegenerative Diseases","enrollment":100},{"nctId":"NCT04468659","phase":"PHASE3","title":"AHEAD 3-45 Study: A Study to Evaluate Efficacy and Safety of Treatment With Lecanemab in Participants With Preclinical Alzheimer's Disease and Elevated Amyloid and Also in Participants With Early Preclinical Alzheimer's Disease and Intermediate Amyloid","status":"ACTIVE_NOT_RECRUITING","sponsor":"Eisai Inc.","startDate":"2020-07-14","conditions":"Preclinical Alzheimer's Disease, Early Preclinical Alzheimer's Disease","enrollment":1400},{"nctId":"NCT05027269","phase":"PHASE1, PHASE2","title":"Study of AOC 1001 in Adult Myotonic Dystrophy Type 1 (DM1) Patients","status":"COMPLETED","sponsor":"Avidity Biosciences, Inc.","startDate":"2021-10-28","conditions":"DM1, Myotonic Dystrophy 1, Myotonic Dystrophy","enrollment":39},{"nctId":"NCT06901531","phase":"PHASE3","title":"A Study of Zolbetuximab Together With Pembrolizumab and Chemotherapy in Adults With Gastric Cancer","status":"RECRUITING","sponsor":"Astellas Pharma Global Development, Inc.","startDate":"2025-05-22","conditions":"Locally Advanced Unresectable Gastroesophageal Junction (GEJ) Adenocarcinoma or Cancer, Locally Advanced Unresectable Gastric Adenocarcinoma or Cancer, Metastatic Gastric Adenocarcinoma or Cancer","enrollment":500},{"nctId":"NCT04895358","phase":"PHASE3","title":"Study of Pembrolizumab (MK-3475) Plus Chemotherapy Versus Placebo Plus Chemotherapy for HR+/HER2- Locally Recurrent Inoperable or Metastatic Breast Cancer (MK-3475-B49/KEYNOTE-B49)","status":"ACTIVE_NOT_RECRUITING","sponsor":"Merck Sharp & Dohme LLC","startDate":"2021-06-18","conditions":"Breast Neoplasms","enrollment":340},{"nctId":"NCT07465198","phase":"PHASE2","title":"Autologous Stem Cell Therapy in Patients With Multiple System Atrophy","status":"NOT_YET_RECRUITING","sponsor":"Biocells Medical","startDate":"2026-09-01","conditions":"MSA - Multiple System Atrophy, MSA","enrollment":50},{"nctId":"NCT04862221","phase":"PHASE2","title":"TReatment for ImmUne Mediated PathopHysiology","status":"RECRUITING","sponsor":"National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)","startDate":"2022-02-09","conditions":"Acute Liver Failure, Fulminant Hepatic Failure, Hepatic Encephalopathy","enrollment":163},{"nctId":"NCT03142334","phase":"PHASE3","title":"Safety and Efficacy Study of Pembrolizumab (MK-3475) as Monotherapy in the Adjuvant Treatment of Renal Cell Carcinoma Post Nephrectomy (MK-3475-564/KEYNOTE-564)","status":"COMPLETED","sponsor":"Merck Sharp & Dohme LLC","startDate":"2017-06-09","conditions":"Renal Cell Carcinoma","enrollment":994},{"nctId":"NCT06783309","phase":"PHASE1, PHASE2","title":"CNP-103 in Adolescent and Adult Subjects Ages 12-35 With Recently Diagnosed (Within 6 Months) Stage 3 Type 1 Diabetes (T1D)","status":"RECRUITING","sponsor":"COUR Pharmaceutical Development Company, Inc.","startDate":"2025-05-12","conditions":"Type 1 Diabetes Mellitus, T1D, T1DM","enrollment":72},{"nctId":"NCT04134845","phase":"PHASE2, PHASE3","title":"A Clinical Trial Utilizing Dantrolene in Patients With Ventricular Arrhythmias.","status":"COMPLETED","sponsor":"Vanderbilt University Medical Center","startDate":"2020-08-21","conditions":"Ventricular Tachycardia","enrollment":68},{"nctId":"NCT03221426","phase":"PHASE3","title":"Study of Pembrolizumab (MK-3475) Plus Chemotherapy Versus Placebo Plus Chemotherapy in Participants With Gastric or Gastroesophageal Junction (GEJ) Adenocarcinoma (MK-3475-585/KEYNOTE-585)","status":"COMPLETED","sponsor":"Merck Sharp & Dohme LLC","startDate":"2017-10-09","conditions":"Gastric Cancer, Gastroesophageal Junction Cancer","enrollment":1007},{"nctId":"NCT05116189","phase":"PHASE3","title":"Pembrolizumab/Placebo Plus Paclitaxel With or Without Bevacizumab for Platinum-resistant Recurrent Ovarian Cancer (MK-3475-B96/KEYNOTE-B96/ENGOT-ov65).","status":"ACTIVE_NOT_RECRUITING","sponsor":"Merck Sharp & Dohme LLC","startDate":"2021-12-13","conditions":"Ovarian Cancer, Carcinoma, Ovarian Epithelial, Fallopian Tube Neoplasms","enrollment":643},{"nctId":"NCT07369024","phase":"PHASE2","title":"Sub-dissociative Dose Ketamine in Treatment of Vaso-occlusive Pain Event in Children and Young Adults","status":"RECRUITING","sponsor":"Mohsen Saidinejad","startDate":"2026-04-01","conditions":"Sickle Cell Disease, Vaso-Occlusive Pain Episode in Sickle Cell Disease, Ketamine Infusion","enrollment":120},{"nctId":"NCT07333859","phase":"PHASE4","title":"Effect of IV Lidocaine on Duodenal Peristalsis and Sedation in ERCP","status":"RECRUITING","sponsor":"Ankara City Hospital Bilkent","startDate":"2026-02-11","conditions":"Duodenal Spasm, ERCP, Sedation","enrollment":120},{"nctId":"NCT04882241","phase":"PHASE3","title":"Study of Pembrolizumab (MK-3475) Plus Chemotherapy Versus Placebo Plus Chemotherapy in Participants With Gastric or Gastroesophageal Junction (GEJ) Adenocarcinoma (MK-3475-585/KEYNOTE-585)-China Extension","status":"COMPLETED","sponsor":"Merck Sharp & Dohme LLC","startDate":"2020-07-29","conditions":"Gastric Cancer, Gastroesophageal Junction Cancer","enrollment":120},{"nctId":"NCT03847428","phase":"PHASE3","title":"Assess Efficacy and Safety of Durvalumab Alone or Combined With Bevacizumab in High Risk of Recurrence HCC Patients After Curative Treatment","status":"ACTIVE_NOT_RECRUITING","sponsor":"AstraZeneca","startDate":"2019-04-29","conditions":"Hepatocellular Carcinoma","enrollment":908},{"nctId":"NCT05350774","phase":"PHASE2","title":"Immunotherapy for Neurological Post-Acute Sequelae of SARS-CoV-2","status":"ENROLLING_BY_INVITATION","sponsor":"National Institute of Neurological Disorders and Stroke (NINDS)","startDate":"2023-07-10","conditions":"Systemic Inflammation, Neuroinflammation, Microvascular Thrombosis","enrollment":45},{"nctId":"NCT02362594","phase":"PHASE3","title":"Study of Pembrolizumab (MK-3475) Versus Placebo After Complete Resection of High-Risk Stage III Melanoma (MK-3475-054/1325-MG/KEYNOTE-054)","status":"ACTIVE_NOT_RECRUITING","sponsor":"Merck Sharp & Dohme LLC","startDate":"2015-07-16","conditions":"Melanoma","enrollment":1019},{"nctId":"NCT07452094","phase":"EARLY_PHASE1","title":"What is the Role of Type III/IV Muscle Afferents in Airway Resistance and Thermoregulatory Responses to Exercise?","status":"NOT_YET_RECRUITING","sponsor":"Northern Arizona University","startDate":"2026-04-01","conditions":"Placebo - Control, Experimental","enrollment":15},{"nctId":"NCT07246863","phase":"PHASE2","title":"Trial Investigating Visugromab and Nivolumab With or Without Docetaxel in 2L Treatment of Participants With Metastatic NSCLC","status":"RECRUITING","sponsor":"CatalYm GmbH","startDate":"2025-10-07","conditions":"Metastatic Non-Squamous Non-Small Cell Lung Cancer, Adult Solid Tumor","enrollment":131},{"nctId":"NCT01983241","phase":"PHASE3","title":"Efficacy and Safety of Alpha1-Proteinase Inhibitor (Human), Modified Process (Alpha-1 MP) in Subjects With Pulmonary Emphysema Due to Alpha1 Antitrypsin Deficiency (AATD)","status":"ACTIVE_NOT_RECRUITING","sponsor":"Grifols Therapeutics LLC","startDate":"2013-11","conditions":"Pulmonary Emphysema in Alpha-1 PI Deficiency","enrollment":345},{"nctId":"NCT07424001","phase":"PHASE4","title":"Preemptive IV Ibuprofen for Neurocognitive Recovery and Analgesic Needs After Inguinal Hernia Surgery","status":"COMPLETED","sponsor":"Mehmet Çiğdem","startDate":"2025-09-27","conditions":"Inguinal Hernia Unilateral, Delayed Neurocognitive Recovery, Postoperative Pain","enrollment":76},{"nctId":"NCT05171894","phase":"PHASE2","title":"A Study to Evaluate Efficacy and Safety of Light Dose in Subjects With PWB Treated With Hemoporfin PDT","status":"RECRUITING","sponsor":"Shanghai Fudan-Zhangjiang Bio-Pharmaceutical Co., Ltd.","startDate":"2024-09-21","conditions":"Port-wine Birthmarks, Port-Wine Stain, Nevus Flammeus","enrollment":84},{"nctId":"NCT06667453","phase":"PHASE2","title":"A Clinical Study of PGN-EDODM1 in People With Myotonic Dystrophy Type 1","status":"RECRUITING","sponsor":"PepGen Inc","startDate":"2024-12-10","conditions":"Myotonic Dystrophy 1","enrollment":24},{"nctId":"NCT06079671","phase":"PHASE3","title":"Study of Volrustomig in Women With High Risk Locally Advanced Cervical Cancer (eVOLVE-Cervical)","status":"RECRUITING","sponsor":"AstraZeneca","startDate":"2023-09-22","conditions":"Locally Advanced Cervical Cancer","enrollment":800},{"nctId":"NCT07439848","phase":"PHASE1, PHASE2","title":"Mesenchymal Stem Cells (MSCs) and Conditioned Medium Mesenchymal Stem Cells as Adjuvant Therapy for Sepsis","status":"RECRUITING","sponsor":"PT. Prodia Stem Cell Indonesia","startDate":"2023-12-25","conditions":"Acute Respiratory Distress Syndrome","enrollment":15},{"nctId":"NCT03552705","phase":"PHASE2","title":"The Effects of Tranexamic Acid on Joint Inflammation and Cartilage Health in Anterior Cruciate Ligament Injured Patients","status":"RECRUITING","sponsor":"Stanford University","startDate":"2019-08-01","conditions":"Anterior Cruciate Ligament Reconstruction","enrollment":50},{"nctId":"NCT05832034","phase":"PHASE2, PHASE3","title":"Add-on Intravenous Immunoglobulins in Early Myositis","status":"ACTIVE_NOT_RECRUITING","sponsor":"Academisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA)","startDate":"2021-09-13","conditions":"Inflammatory Myopathy, Idiopathic, Dermatomyositis, Antisynthetase Syndrome","enrollment":44},{"nctId":"NCT05279768","phase":"PHASE1, PHASE2","title":"Stem Cells and Secretomes for Infertility Therapy in Polycystic Ovary Syndrome (PCOS) Patients With Insulin Resistance.","status":"COMPLETED","sponsor":"PT. Prodia Stem Cell Indonesia","startDate":"2022-09-01","conditions":"Polycystic Ovary Syndrome","enrollment":44},{"nctId":"NCT07429448","phase":"PHASE1","title":"Comparison Of Clinical Outcomes of Intraperitoneal Bupivacaine Instillation Versus Placebo as Preemptive Analgesia in Patients Undergoing Open Appendectomy","status":"RECRUITING","sponsor":"Sardar Umer Rehman","startDate":"2025-12-16","conditions":"Appendectomy","enrollment":60},{"nctId":"NCT07430228","phase":"PHASE2","title":"Efficacy of Intravenous Oxytocin to Speed Recovery After THA","status":"NOT_YET_RECRUITING","sponsor":"Wake Forest University Health Sciences","startDate":"2026-05","conditions":"Total Hip Arthroplasty","enrollment":80},{"nctId":"NCT05585606","phase":"PHASE2","title":"Study of the Safety and Neuroprotective Capacity of Scp776 in Acute Ischemic Stroke","status":"COMPLETED","sponsor":"Silver Creek Pharmaceuticals","startDate":"2022-10-19","conditions":"Acute Ischemic Stroke (AIS)","enrollment":120},{"nctId":"NCT07360301","phase":"PHASE1","title":"Consciousness and Psilocybin Effects on Well-Being: The CoPEWell Study","status":"NOT_YET_RECRUITING","sponsor":"University of Wisconsin, Madison","startDate":"2026-04","conditions":"Well-Being, Psychological, Psychedelic Experiences","enrollment":120},{"nctId":"NCT06219317","phase":"PHASE2","title":"Immunotherapy Consolidation After Radical Treatment of Synchronous Oligo-metastatic NSCLC","status":"RECRUITING","sponsor":"European Organisation for Research and Treatment of Cancer - EORTC","startDate":"2025-01-14","conditions":"NSCLC Stage IV","enrollment":136},{"nctId":"NCT06650761","phase":"PHASE1","title":"A Phase I Study of CDX-622","status":"ACTIVE_NOT_RECRUITING","sponsor":"Celldex Therapeutics","startDate":"2024-11-01","conditions":"Healthy Participants","enrollment":85},{"nctId":"NCT00699751","phase":"PHASE3","title":"A Phase III Study of Radium-223 Dichloride in Patients With Symptomatic Hormone Refractory Prostate Cancer With Skeletal Metastases","status":"COMPLETED","sponsor":"Bayer","startDate":"2008-06-12","conditions":"Hormone Refractory Prostate Cancer, Bone Metastases","enrollment":921},{"nctId":"NCT07423000","phase":"PHASE1","title":"A Phase 1 Study of PVT401 in Healthy Subjects","status":"NOT_YET_RECRUITING","sponsor":"Parvus Therapeutics, Inc.","startDate":"2026-04","conditions":"Inflammatory Bowel Disease (IBD)","enrollment":36},{"nctId":"NCT06305780","phase":"PHASE2","title":"RECOVER-AUTONOMIC Platform Protocol","status":"COMPLETED","sponsor":"Kanecia Obie Zimmerman","startDate":"2024-03-11","conditions":"Long COVID, Long Covid19, Long Covid-19","enrollment":381},{"nctId":"NCT01649765","phase":"PHASE2","title":"Pediatric Lupus Trial of Belimumab Plus Background Standard Therapy","status":"COMPLETED","sponsor":"GlaxoSmithKline","startDate":"2012-09-07","conditions":"Systemic Lupus Erythematosus","enrollment":93},{"nctId":"NCT06994442","phase":"PHASE3","title":"Optimizing Pain Treatment in Children On Mechanical Ventilation","status":"RECRUITING","sponsor":"Weill Medical College of Cornell University","startDate":"2025-12-29","conditions":"Mechanical Ventilation, Pediatric Acute Respiratory Failure, Analgesics, Opioid","enrollment":644},{"nctId":"NCT04742673","phase":"PHASE2","title":"Maximizing trEatment of Neurological Dysfunction Using INtravenous Guanfacine Study","status":"COMPLETED","sponsor":"Vanderbilt University Medical Center","startDate":"2021-05-04","conditions":"Critical Illness, Delirium, Cognitive Impairment","enrollment":46},{"nctId":"NCT04945707","phase":"PHASE4","title":"Impact of Intravenous Iron Repletion On Mechanisms of Exercise InTolerance in HFpEF (IRONMET-HFpEF)","status":"RECRUITING","sponsor":"Massachusetts General Hospital","startDate":"2021-11-26","conditions":"Iron-deficiency, Heart Failure With Preserved Ejection Fraction","enrollment":66},{"nctId":"NCT03929601","phase":"PHASE2","title":"Rituximab-pvvr and Abatacept vs Rituximab-pvvr Alone in New Onset Type 1 Diabetes","status":"ACTIVE_NOT_RECRUITING","sponsor":"National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)","startDate":"2023-10-30","conditions":"Type 1 Diabetes Mellitus","enrollment":74},{"nctId":"NCT07419815","phase":"NA","title":"IV Lidocaine Infusion Versus Placebo for Pain Control in Staging Laparoscopy Cases","status":"ACTIVE_NOT_RECRUITING","sponsor":"Shaukat Khanum Memorial Cancer Hospital & Research Centre","startDate":"2025-12-03","conditions":"Side Effects of Opoid Consumption","enrollment":62},{"nctId":"NCT03295383","phase":"PHASE3","title":"Randomized Clinical Trial Comparing the Safety and Efficacy of Rituximab Versus Oral Cyclophosphamide in Severe Forms of Mucous Membrane Pemphigoid","status":"RECRUITING","sponsor":"University Hospital, Rouen","startDate":"2019-07-11","conditions":"Severe Forms of Mucous Membrane Pemphigoid","enrollment":130},{"nctId":"NCT07417969","phase":"NA","title":"\"Effect of Albumin Combined With Furosemide in Critically Ill Patients With Fluid Overload: Impact on Urine Output and Renal Function\"","status":"RECRUITING","sponsor":"Jose J Zaragoza, MD MSc","startDate":"2025-06-01","conditions":"Urine Output Decreased","enrollment":56},{"nctId":"NCT04886284","phase":"PHASE2","title":"Combination Cefazolin With Ertapenem for Methicillin-susceptible Staphylococcus Aureus Bacteremia","status":"RECRUITING","sponsor":"Todd C. Lee MD MPH FIDSA","startDate":"2024-05-20","conditions":"Staphylococcus Aureus Bacteremia, Staphylococcus Aureus Septicemia, Staphylococcal Sepsis","enrollment":60},{"nctId":"NCT05058976","phase":"PHASE4","title":"Romosozumab Use to Build Skeletal Integrity","status":"ACTIVE_NOT_RECRUITING","sponsor":"Susan L. Greenspan","startDate":"2021-09-15","conditions":"Osteoporosis, Osteoporosis, Postmenopausal, Osteoporosis Fracture","enrollment":184},{"nctId":"NCT05345171","phase":"PHASE3","title":"Clinical Study of DTX301 AAV-Mediated Gene Transfer for Ornithine Transcarbamylase (OTC) Deficiency","status":"ACTIVE_NOT_RECRUITING","sponsor":"Ultragenyx Pharmaceutical Inc","startDate":"2022-10-18","conditions":"OTC Deficiency","enrollment":32},{"nctId":"NCT07409753","phase":"PHASE2","title":"Effects Of Intravenous Oxytocin On Peripheral Sensory Afferents Using Microneurography","status":"RECRUITING","sponsor":"Wake Forest University Health Sciences","startDate":"2025-10-22","conditions":"Acute Pain","enrollment":60},{"nctId":"NCT05233566","phase":"PHASE3","title":"Ketamine for Postoperative Avoidance of Depressive Symptoms: The K-PASS Feasibility Trial","status":"COMPLETED","sponsor":"Washington University School of Medicine","startDate":"2022-04-25","conditions":"Postoperative Depression","enrollment":32},{"nctId":"NCT07167693","phase":"PHASE1, PHASE2","title":"Phase 1 Trial of Arginine Hydrochloride for the Management of Diabetic Ketoacidosis in Type 2 Diabetes","status":"RECRUITING","sponsor":"David K Carroll","startDate":"2025-12-19","conditions":"Diabetes (DM), Diabetic Ketoacidosis, Ketosis Prone Diabetes","enrollment":60},{"nctId":"NCT05027074","phase":"PHASE2","title":"Global Study of MK-2060 (Anti-Factor XI Monoclonal Antibody) in Participants With End Stage Renal Disease Receiving Hemodialysis (FXI Hemodialysis Study) (MK-2060-007)","status":"COMPLETED","sponsor":"Merck Sharp & Dohme LLC","startDate":"2021-09-17","conditions":"End-Stage Renal Disease, End-Stage Kidney Disease, Kidney Failure, Chronic","enrollment":506},{"nctId":"NCT04368559","phase":"PHASE3","title":"Study of Rezafungin Compared to Standard Antimicrobial Regimen for Prevention of Invasive Fungal Diseases in Adults Undergoing Allogeneic Blood and Marrow Transplantation","status":"ACTIVE_NOT_RECRUITING","sponsor":"Mundipharma Research Limited","startDate":"2020-05-11","conditions":"Candidemia, Mycoses, Fungal Infection","enrollment":602},{"nctId":"NCT06287619","phase":"PHASE2","title":"Post-operative Intravenous Iron to Treat Iron-deficiency Anemia in Patients Undergoing Cardiac Surgery","status":"RECRUITING","sponsor":"University Health Network, Toronto","startDate":"2025-04-03","conditions":"Chronic Iron Deficiency Anaemia, Cardiac Surgery","enrollment":60},{"nctId":"NCT06575153","phase":"PHASE1","title":"Phase 1 Study of ART5803 in Healthy Participants","status":"ACTIVE_NOT_RECRUITING","sponsor":"Arialys Therapeutics","startDate":"2024-09-19","conditions":"Autoimmune Encephalitis","enrollment":64},{"nctId":"NCT05929677","phase":"EARLY_PHASE1","title":"Impulsivity Domains and Subjective Response","status":"RECRUITING","sponsor":"Jessica Weafer","startDate":"2024-04-01","conditions":"Alcohol Use Disorder","enrollment":250},{"nctId":"NCT04918147","phase":"PHASE2","title":"Elotuzumab in Immunoglobulin G4-Related Disease (IgG4-RD)","status":"TERMINATED","sponsor":"National Institute of Allergy and Infectious Diseases (NIAID)","startDate":"2021-10-13","conditions":"IgG4 Related Disease, IgG4-RD","enrollment":8},{"nctId":"NCT03713593","phase":"PHASE3","title":"Safety and Efficacy of Lenvatinib (E7080/MK-7902) in Combination With Pembrolizumab (MK-3475) Versus Lenvatinib as First-line Therapy in Participants With Advanced Hepatocellular Carcinoma (MK-7902-002/E7080-G000-311/LEAP-002)","status":"COMPLETED","sponsor":"Merck Sharp & Dohme LLC","startDate":"2018-12-31","conditions":"Carcinoma, Hepatocellular","enrollment":794},{"nctId":"NCT05306899","phase":"PHASE3","title":"Multi-center RCT of IV Ketamine Efficacy and Safety in Chronic Daily Headaches","status":"RECRUITING","sponsor":"University Health Network, Toronto","startDate":"2022-06-01","conditions":"Chronic Daily Headache","enrollment":56},{"nctId":"NCT03040999","phase":"PHASE3","title":"Study of Pembrolizumab (MK-3475) or Placebo With Chemoradiation in Participants With Locally Advanced Head and Neck Squamous Cell Carcinoma (MK-3475-412/KEYNOTE-412)","status":"COMPLETED","sponsor":"Merck Sharp & Dohme LLC","startDate":"2017-04-05","conditions":"Head and Neck Neoplasms","enrollment":804},{"nctId":"NCT03867084","phase":"PHASE3","title":"Safety and Efficacy of Pembrolizumab (MK-3475) Versus Placebo as Adjuvant Therapy in Participants With Hepatocellular Carcinoma (HCC) and Complete Radiological Response After Surgical Resection or Local Ablation (MK-3475-937 / KEYNOTE-937)","status":"COMPLETED","sponsor":"Merck Sharp & Dohme LLC","startDate":"2019-05-28","conditions":"Hepatocellular Carcinoma","enrollment":959},{"nctId":"NCT03635567","phase":"PHASE3","title":"Efficacy and Safety Study of First-line Treatment With Pembrolizumab (MK-3475) Plus Chemotherapy Versus Placebo Plus Chemotherapy in Women With Persistent, Recurrent, or Metastatic Cervical Cancer (MK-3475-826/KEYNOTE-826)","status":"COMPLETED","sponsor":"Merck Sharp & Dohme LLC","startDate":"2018-10-25","conditions":"Cervical Cancer","enrollment":617},{"nctId":"NCT07160205","phase":"PHASE2, PHASE3","title":"Safety and Efficacy of ULSC on Disease Severity and Steroid Tapering in Participants With Dermatomyositis/ Polymyositis (DM/PM), Also Known as Idiopathic Inflammatory Myopathy (IIM)","status":"RECRUITING","sponsor":"Restem, LLC.","startDate":"2026-01-06","conditions":"Idiopathic Inflammatory Myositis (IIM), DERMATOMYOSITIS OR POLYMYOSITIS","enrollment":40},{"nctId":"NCT05953480","phase":"PHASE2","title":"A Phase 2b, Randomized, Double-blind Study of Redasemtide (S-005151) in Adult Participants With Acute Ischemic Stroke","status":"ACTIVE_NOT_RECRUITING","sponsor":"Shionogi","startDate":"2023-07-14","conditions":"Acute Ischemic Stroke","enrollment":680},{"nctId":"NCT07379866","phase":"NA","title":"Glossopharyngeal and Maxillary Nerve Blocks in Adenotonsillectomy","status":"RECRUITING","sponsor":"Cairo University","startDate":"2026-01","conditions":"Regional, Adenotonsillectomy","enrollment":40},{"nctId":"NCT07366710","phase":"NA","title":"Measuring Amino Acid and Glucose Metabolism in Healthy Volunteers and NAFLD Patients Using Total-body PET","status":"ACTIVE_NOT_RECRUITING","sponsor":"Rigshospitalet, Denmark","startDate":"2024-11-05","conditions":"Glucose Metabolism, NAFLD (Nonalcoholic Fatty Liver Disease)","enrollment":36},{"nctId":"NCT05856890","phase":"PHASE1","title":"HepB mAb19 in Individuals With Chronic Hepatitis B Infection","status":"RECRUITING","sponsor":"Rockefeller University","startDate":"2023-08-07","conditions":"Hepatitis b Virus, Hepatitis B","enrollment":37},{"nctId":"NCT07359599","phase":"PHASE4","title":"The Impact of IV Iron on Exercise Capacity and Quality of Life in Pulmonary Hypertension","status":"RECRUITING","sponsor":"Ziekenhuis Oost-Limburg","startDate":"2026-01-27","conditions":"Pulmonary Hypertension, Iron Deficiency","enrollment":306},{"nctId":"NCT05952804","phase":"PHASE2","title":"IVIG for Infection Prevention After CAR-T-Cell Therapy","status":"RECRUITING","sponsor":"Fred Hutchinson Cancer Center","startDate":"2024-06-10","conditions":"Hematologic Malignancies","enrollment":150},{"nctId":"NCT05505630","phase":"EARLY_PHASE1","title":"The Effects of Sedatives on Tobacco Use Disorder Version 2","status":"COMPLETED","sponsor":"Wake Forest University Health Sciences","startDate":"2023-01-31","conditions":"Tobacco Smoking","enrollment":20},{"nctId":"NCT05776004","phase":"PHASE2","title":"Blinded Efficacy and Safety Study of CAL02 IV Plus SOC in Subjects With Severe Community-Acquired Bacterial Pneumonia","status":"ACTIVE_NOT_RECRUITING","sponsor":"Eagle Pharmaceuticals, Inc.","startDate":"2023-07-22","conditions":"Pneumonia, Bacterial","enrollment":276},{"nctId":"NCT05879432","phase":"PHASE2","title":"LSALT Peptide for Prevention or Attenuation of Acute Kidney Injury (AKI) in Patients Undergoing On-Pump Cardiac Surgery","status":"RECRUITING","sponsor":"Arch Biopartners Inc.","startDate":"2024-03-08","conditions":"Acute Kidney Injury, Cardiac Surgery","enrollment":240},{"nctId":"NCT07368790","phase":"NA","title":"Elective Total Abdominal Hysterectomy With Preoperative Analgesia Intravenous Paracetamol Versus Placebo","status":"COMPLETED","sponsor":"Queen Savang Vadhana Memorial Hospital, Thailand","startDate":"2024-10-10","conditions":"Postoperative Pain","enrollment":40},{"nctId":"NCT05220319","phase":"PHASE4","title":"CORTERAS STUDY: The Effect of Corticosteroids on Early Recovery After Major Surgery in Elderly Patients","status":"COMPLETED","sponsor":"Ziekenhuis Oost-Limburg","startDate":"2022-02-16","conditions":"Inflammatory Response, Weakness, Muscle","enrollment":751},{"nctId":"NCT06411288","phase":"PHASE3","title":"Global Study of Del-desiran for the Treatment of DM1","status":"ACTIVE_NOT_RECRUITING","sponsor":"Avidity Biosciences, Inc.","startDate":"2024-05-30","conditions":"DM1, Myotonic Dystrophy, Myotonic Dystrophy 1","enrollment":159},{"nctId":"NCT04803747","phase":"PHASE4","title":"A Trial of a Hospital Policy of Tranexamic Acid Use to Reduce Transfusion in Major Non-cardiac Surgery","status":"COMPLETED","sponsor":"University of Manitoba","startDate":"2022-02-16","conditions":"Major Non-cardiac Surgeries","enrollment":8421},{"nctId":"NCT07359625","phase":"NA","title":"Effects of Ketone Bodies on Insulin Sensitivity","status":"RECRUITING","sponsor":"University of Aarhus","startDate":"2025-12-02","conditions":"Insulin Resistance, Obesity & Overweight, Energy Metabolism","enrollment":10}],"_emaApprovals":[],"_faersSignals":[],"_approvalHistory":[],"publicationCount":0,"rwe":[],"genericFilers":[],"relatedDrugs":[],"labelChanges":[],"biosimilarFilings":[],"pricing":[],"formularyStatus":[],"manufacturing":[],"companionDiagnostics":[],"competitors":[],"timeline":[],"patents":[],"ownershipHistory":[],"trials":[],"biosimilars":[],"latestUpdates":[],"references":[],"tags":[],"ecosystem":[],"genericManufacturerList":[],"offLabel":[],"developmentCodes":[],"aliases":["Saline"],"phase":"marketed","status":"active","brandName":"IV Placebo (Saline)","genericName":"IV Placebo (Saline)","companyName":"Allergan","companyId":"allergan","modality":"Small molecule","firstApprovalDate":"","aiSummary":"IV saline placebo has no active pharmacological mechanism; it is a control comparator consisting of sterile sodium chloride solution. Used for Clinical trial control / placebo comparator (not a therapeutic indication).","enrichmentLevel":3,"visitCount":1,"trialStats":{"total":0,"withResults":0},"verificationStatus":"verified","dataCompleteness":{"mechanism":true,"indications":true,"safety":true,"trials":true,"score":4}}